Pulmonary sarcomatoid carcinoma: Future prospects of adjuvant immunotherapy in advanced management

Bibliographic Details
Main Author: Anand Agrawal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Lung India
Online Access:http://www.lungindia.com/article.asp?issn=0970-2113;year=2020;volume=37;issue=6;spage=540;epage=541;aulast=
id doaj-d632675b2d6747e4b59f236f838c675f
record_format Article
spelling doaj-d632675b2d6747e4b59f236f838c675f2020-11-25T04:03:46ZengWolters Kluwer Medknow PublicationsLung India0970-21130974-598X2020-01-0137654054110.4103/lungindia.lungindia_399_20Pulmonary sarcomatoid carcinoma: Future prospects of adjuvant immunotherapy in advanced managementAnand Agrawalhttp://www.lungindia.com/article.asp?issn=0970-2113;year=2020;volume=37;issue=6;spage=540;epage=541;aulast=
collection DOAJ
language English
format Article
sources DOAJ
author Anand Agrawal
spellingShingle Anand Agrawal
Pulmonary sarcomatoid carcinoma: Future prospects of adjuvant immunotherapy in advanced management
Lung India
author_facet Anand Agrawal
author_sort Anand Agrawal
title Pulmonary sarcomatoid carcinoma: Future prospects of adjuvant immunotherapy in advanced management
title_short Pulmonary sarcomatoid carcinoma: Future prospects of adjuvant immunotherapy in advanced management
title_full Pulmonary sarcomatoid carcinoma: Future prospects of adjuvant immunotherapy in advanced management
title_fullStr Pulmonary sarcomatoid carcinoma: Future prospects of adjuvant immunotherapy in advanced management
title_full_unstemmed Pulmonary sarcomatoid carcinoma: Future prospects of adjuvant immunotherapy in advanced management
title_sort pulmonary sarcomatoid carcinoma: future prospects of adjuvant immunotherapy in advanced management
publisher Wolters Kluwer Medknow Publications
series Lung India
issn 0970-2113
0974-598X
publishDate 2020-01-01
url http://www.lungindia.com/article.asp?issn=0970-2113;year=2020;volume=37;issue=6;spage=540;epage=541;aulast=
work_keys_str_mv AT anandagrawal pulmonarysarcomatoidcarcinomafutureprospectsofadjuvantimmunotherapyinadvancedmanagement
_version_ 1724439363375333376